Skip to content

Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility

Effect of Deep Brain Stimulation on Voluntary and Involuntary Gastrointestinal Motility in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01081457
Acronym
SCP-Comodig
Enrollment
16
Registered
2010-03-05
Start date
2010-01-31
Completion date
2012-01-31
Last updated
2012-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, deep brain stimulation, GI motility

Brief summary

Parkinson's disease is characterized by extra-pyramidal symptoms as well as digestive involvement with gastrointestinal motility (GI) impairment. Deep brain stimulation has been recently developed as a successful treatment for extrapyramidal symptoms. In addition, preliminary reports suggest that this therapy might be successful to relieve GI symptoms as well. The aim of this study is therefore to assess the effect of deep brain stimulation on GI voluntary as well as involuntary motility.

Interventions

DEVICEDeep brain stimulation

Comparison ON vs OFF

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient over 18 yo * patient with Parkinson's disease implanted for deep brain stimulation * patient responders to deep brain stimulation (UPDRS improved by at least 40%) * patient covered by the french health care system * patient not taking anti-parkinsonian medication the day before evaluation * French speaking

Exclusion criteria

* patient below 18 yo * pregnancy * Severe psychiatric or cognitive disorders * diabetes mellitus * morbid obesity * compulsive eating disorders * diffuse GI motility impairment (except Parkinson's disease) * other evolutive neurologic disorders * previous history of significant GI resection * inability to swallow or defecate when asked

Design outcomes

Primary

MeasureTime frame
Anal pressure2 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026